Merck KGaA links with AI firm to iron out side-effects during R&D

Merck KGaA links with AI firm to iron out side-effects during R&D

Submitted by admin on December 10, 2018 - 9:56am
Source: 
Pharmaforum
News Tags: 
Merck KGaA
R&D
artificial intelligence
Cyclica
drug development
Headline: 
Merck KGaA links with AI firm to iron out side-effects during R&D
snippet: 

Germany’s Merck KGaA has begun a licensing agreement with Canadian pharma R&D company Cyclica using artificial intelligence (AI) to uncover new drug targets and predict any side effects.

Do Not Allow Advertisers to Use My Personal information